Delivery Order SPE2DB22D3501-SPE2DB25FTQ91

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,097.08 delivery order contract is for the supply of the drug Wegovy (0.5 mg/0.5 ml pen, 0.5 ml) to support federal healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of April 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,764.39 firm fixed-price delivery order is for the supply of Wegovy 0.25 mg/0.5 ml pen medication. The contract has an ultimate completion date of May 9, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,674.86 Firm Fixed Price contract is for the delivery of the prescription medication Wegovy 0.5 mg/0.5 ml pen in 0.5 ml quantities, with a period of performance through October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,641.60 Firm Fixed Price delivery order contract is for the supply of the medication Wegovy 0.25 mg/0.5 ml pen with an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,866.50, is for the delivery of the medication Wegovy 0.5 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price delivery order contract with a period of performance through March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.28 firm-fixed-price delivery order is for the drug Wegovy, a 2.4 mg/0.75 mL pen, with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,022.27 firm fixed-price delivery order is for the supply of Wegovy 0.25 mg/0.5 ml pens. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,916.40, is for the delivery of the medication Wegovy in a 0.5 mg/0.5 ml pen form. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 29, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,484.00 firm fixed price delivery order is for the supply of Wegovy 0.25 mg/0.5 ml pens. The award has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $4,326.97 and is a delivery order for the drug Wegovy 1 mg/0.5 ml pen 0.5 ml. The contract is a firm fixed price contract with an ultimate completion date of March 12, 2025. AmerisourceBergen is the prime contractor, and the contract is not designated as a set-aside. The contract is...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTQ91
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,095.00 Firm Fixed Price contract is for the delivery of the drug Wegovy 0.25 mg/0.5 ml pen in 0.5 ml quantity, with a completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 2/26/25, 9:53 AM